Crossref
Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology
Eurasian Journal of Medicine and Oncology · 18.11.2026 · 026440606
DOI: 10.36922/ejmo026440606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 18.11.2026. Verfasst von Dirk Geerts.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Geerts, D. (2026). Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology. Eurasian Journal of Medicine and Oncology, 0(0), 026440606. https://doi.org/10.36922/ejmo026440606
Vancouver
Geerts D. Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology. Eurasian Journal of Medicine and Oncology. 2026;0(0):026440606. doi:10.36922/ejmo026440606
BibTeX
@article{Geerts2026,
author = {Geerts, Dirk},
title = {Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {026440606},
doi = {10.36922/ejmo026440606}
}
EUVIMED